We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Genoprotective potential of Macaranga species phytochemical compounds on HT-29 human colorectal adenocarcinoma cell line

    Background

    The species of genus Macaranga are widely found in Malaysian secondary forests and has been used as an alternative for treating varieties...

    Ee Ling Siew, Lishantini Pearanpan, ... Nor Fadilah Rajab in Genes and Environment
    Article Open access 30 October 2023
  2. Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study

    Purpose

    To assess whether androgens play a role in explaining the sex related differences in the incidence of colorectal cancer (CRC).

    ...
    Richard Shore, Ji Zhang, ... Mats Lindblad in Cancer Causes & Control
    Article Open access 21 June 2023
  3. Immunohistochemical analysis of Tn antigen expression in colorectal adenocarcinoma and precursor lesions

    Background

    The Tn antigen (CD175) is an O-glycan expressed in various types of human adenocarcinomas, including colorectal cancer (CRC), though prior...

    Gabrielle E. Dombek, Ana Sofia Ore, ... Richard D. Cummings in BMC Cancer
    Article Open access 07 December 2022
  4. The circadian clock circuitry deconvolutes colorectal cancer and lung adenocarcinoma heterogeneity in a dynamic time-related framework

    Increasing evidence imputes cancer progression and resistance to therapy to intra-tumor molecular heterogeneity set off by cancer cell plasticity....

    Valentina Melocchi, Roberto Cuttano, ... Fabrizio Bianchi in Cancer Gene Therapy
    Article 21 July 2023
  5. Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched study

    Background

    This study aims to investigate the clinical significance and prognostic value of mucinous component (MC) in colorectal adenocarcinoma (AC).

    ...
    Chuanwang Yan, Hui Yang, ... Lijian **a in BMC Cancer
    Article Open access 01 December 2021
  6. Rab3B enhances the stabilization of DDX6 to promote lung adenocarcinoma aggressiveness

    Background

    Liver kinase B1 ( LKB1 ) is frequently mutated in lung adenocarcinoma, and its loss contributes to tumor progression.

    Methods ...
    Guodong Yao, Shan Yu, ... Jigang Wang in Molecular Medicine
    Article Open access 04 June 2024
  7. Comprehensive analysis of cuproptosis-related long noncoding RNA for predicting prognostic and diagnostic value and immune landscape in colorectal adenocarcinoma

    Background

    Cuproptosis, as a copper-induced mitochondrial cell death, has attracted extensive attention recently, especially in cancer. Although some...

    Shichao Liu, Shoucai Zhang, ... Guixi Zheng in Human Genomics
    Article Open access 13 March 2023
  8. Azoxymethane/Dextran Sodium Sulfate (AOM/DSS) Model of Colorectal Cancer

    Recent progress in develo** new vaccination strategies against cancer requires the production of complex and reliable animal models reflecting the...
    Mariangela De Robertis, Emanuela Signori in Mouse Models of Cancer
    Protocol 2024
  9. Amino acids and risk of colon adenocarcinoma: a Mendelian randomization study

    Background

    The existence of amino acid metabolic reprogramming in tumor cells is well established. However, the potential correlation between blood...

    Yuanyuan Wang, Zhihan Jia, ... Zhitu Zhu in BMC Cancer
    Article Open access 28 October 2023
  10. Effects of Boron Neutron Capture Therapy on the Growth of Subcutaneous Xenografts of Human Colorectal Adenocarcinoma SW-620 in Immunodeficient Mice

    Boron neutron capture therapy (BNCT) can become an instrument for patients with malignant neoplasms of the rectum and colon. Here we evaluate the...

    V. V. Kanygin, A. I. Kasatova, ... V. A. Byvaltsev in Bulletin of Experimental Biology and Medicine
    Article 10 January 2022
  11. Colorectal Cancer and Role of Biomarkers in Diagnosis, Prognostification and Personalized Treatment

    Colorectal cancer (CRC) is the second leading cause of cancer-related mortality worldwide as per GLOBOCAN 2020. One out of five patients is diagnosed...
    Divya Khosla, Aditya Kumar Singla, ... Rakesh Kapoor in Molecular Biomarkers for Cancer Diagnosis and Therapy
    Chapter 2024
  12. Mucinous Colorectal Cancer Oxidative Stress and Therapeutic MicroRNAs

    Colorectal Cancer (CRC) is the third most leading cause of cancer related death worldwide and has a diverse clinical etiology. Mounting evidences has...
    Harsha Ganesan, M. K. Makalakshmi, ... Surajit Pathak in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Living reference work entry 2022
  13. Mucinous Colorectal Cancer Oxidative Stress and Therapeutic MicroRNAs

    Colorectal Cancer (CRC) is the third most leading cause of cancer related death worldwide and has a diverse clinical etiology. Mounting evidences has...
    Harsha Ganesan, M. K. Makalakshmi, ... Surajit Pathak in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Reference work entry 2022
  14. Gut microbiota-mediated activation of GSDMD ignites colorectal tumorigenesis

    Activation of Gasdermin D (GSDMD) results in its cleavage, oligomerization, and subsequent formation of plasma membrane pores, leading to a form of...

    Ju Chen, Neha Singh, ... Kepeng Wang in Cancer Gene Therapy
    Article Open access 19 June 2024
  15. Orthotopic MC-38 Allograft as a Robust Preclinical Model of Colorectal Carcinoma

    Colorectal cancer (CRC) is a significant global health concern, requiring effective preclinical models for studying its development and testing...
    Marina H. Yakou, Shoukat Afshar-Sterle, ... Lisa A. Mielke in Patient-Derived Xenografts
    Protocol 2024
  16. A pan-cancer analysis indicates long noncoding RNA HAND2-AS1 as a potential prognostic, immunomodulatory and therapeutic biomarker in various cancers including colorectal adenocarcinoma

    The HAND2-AS1 (HAND2 Antisense RNA 1) Long noncoding RNA (lncRNA) has emerged as a participant in the initiation of various cancer types,...

    Pouria Samadi, Mina Shahnazari, ... Akram Jalali in Cancer Cell International
    Article Open access 02 December 2023
  17. Construction of 11 metabolic-related lncRNAs to predict the prognosis in lung adenocarcinoma

    Objective

    To explore the metabolism-related lncRNAs in the tumorigenesis of lung adenocarcinoma.

    Methods

    The transcriptome data and clinical...

    Wei Jiang, Zhanyu Xu, ... Shikang Li in BMC Medical Genomics
    Article Open access 18 December 2023
  18. Identification of Cancer-Associated Fibroblasts in Metastatic Lymph Nodes of Colorectal Carcinoma

    Cancer-associated fibroblasts (CAF) are a heterogeneous group of tumor microenvironment cells that are barely studied in metastatic lymph nodes. The...

    N. A. Oleynikova, O. A. Kharlova, ... N. D. Danilova in Bulletin of Experimental Biology and Medicine
    Article 01 March 2023
  19. Analysis of cancer-associated fibroblasts related genes identifies COL11A1 associated with lung adenocarcinoma prognosis

    Background

    The treatment of lung adenocarcinoma is difficult due to the limited therapeutic options. Cancer-associated fibroblasts play an important...

    Haosheng Zheng, Jian Tan, ... Hongying Liao in BMC Medical Genomics
    Article Open access 22 April 2024
  20. Forkhead box E1, frequently downregulted by promoter methylation, inhibits colorectal cancer cell growth and migration

    Forkhead box E1 ( FOXE1 ), also known as thyroid transcription factor 2 ( TTF-2 ), belongs to a large family of forkhead transcription factors. It plays...

    Qinlan Shi, Zhongting Huang, ... **aotong Hu in Cancer Cell International
    Article Open access 11 May 2024
Did you find what you were looking for? Share feedback.